Insider trade

Officer sold ~$725K of DGX shares in the open market

Traded Feb 13, 2026 · Filed Feb 17, 2026

~$725K
Reported value · 3,500 sh @ $207.0822: 70K
Holds after · shares reported: +11.7%
stock since the trade · S&P 500 +12.1%, $206.87 → $231.09 on Oct 1

Why it stands out

Quest Diagnostics's Regional Businesses sold $725K of Quest Diagnostics shares. It was planned long ago, so it says very little.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Feb 13, 2026
Reporting period: Not applicable
Filed with the SEC: Feb 17, 2026

Officer$500K–$1MPre-arranged plan referenced

Context

Classification

open market sale

Code S — open-market or private sale

Absolute commitment

~$724,788

Shares × reported transaction price

Timing vs results

3 days after results of Feb 10, 2026, 67 days before results of Apr 21, 2026

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Price at the time

Closed at $206.87 on Feb 13, 2026, within 2% of its 52-week high, after a 19% rise over the previous 30 trading days

52-week range $159.80 (Apr 8, 2025) to $209.32 (Feb 11, 2026), 95% of the way up, from 251 adjusted closes. 30 trading days earlier: $173.53 on Dec 31, 2025. Describes the past only, not a forecast

Planned / mechanical clue

Footnote references a pre-arranged trading plan (Rule 10b5-1)

Only flagged when a footnote says so; never inferred

After it was reported

After	Stock	S&P 500	Difference
7 days	+1.7%	+1.0%	+0.7%
30 days	-4.5%	-5.5%	+1.0%
90 days	-6.8%	+6.9%	-13.8%
180 days	+15.2%	+12.6%	+2.6%

Past results only. Not a forecast.

Source receipt

Record ID: 0001022079-26-000009
Filed / recorded: Feb 17, 2026, 9:37 PM UTC
Added to OQRO: Oct 2, 2026, 12:28 PM UTC
Parser: form4-xml-v1
Data quality: Verified: identifiers matched exactly
Issuer: QUEST DIAGNOSTICS INC
Issuer CIK: 1022079
Ticker: DGX
Reporting person: Catherine T. Doherty
Relationship: Officer
Officer title: EVP, Regional Businesses
Security: Common Stock
Table: Non-derivative (Table I)
Transaction date: Feb 13, 2026
Transaction code: S
Shares / units: 3,500
Price per share: $207.0822
Acquired / disposed: Disposed (D)
Shares owned after: 70,038
Ownership form: Direct
Amendment: No

Footnotes from the filing

This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.
This transaction was executed in multiple trades at prices ranging from $206.770 to $207.675. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Around the same time

7mo ago

215Shares

Compensation award — excluded from discretionary-purchase analysis.

Why it stands out Official record

7mo ago

14KShares · @ $204.86

Compensation award — excluded from discretionary-purchase analysis.

Why it stands out Official record

7mo ago

7,720Shares · @ $204.86

Routine share withholding; mechanical by default.

Why it stands out Official record